The complexity of kidney disease secondary to collagen IV variants: insights into phenotypic variability from a large Sicilian pedigree
- PMID: 40522375
- DOI: 10.1007/s40620-025-02321-6
The complexity of kidney disease secondary to collagen IV variants: insights into phenotypic variability from a large Sicilian pedigree
Abstract
Background: Collagen type IV (COL IV) is a crucial component of basement membranes, including the glomerular basement membrane (GBM), essential for kidney function. COL4A3, COL4A4, and COL4A5 variants lead to a broad spectrum of kidney disorders. This paper investigates the clinical and genetic characteristics of a large Sicilian family with COL4A gene abnormalities.
Methods: Starting from a male patient with digenic Alport Syndrome, we collected clinical data through genealogical research and performed genetic analyses on nineteen members of his family. Kidney biopsies were available for three of them.
Results: We identified variants in COL4A5 and COL4A3 genes. Clinical and histological manifestations varied widely, even among individuals with the same variant, highlighting the remarkable phenotypic heterogeneity of collagen IV-related nephropathies.
Conclusions: Our findings underscore the pivotal role of genetic testing in guiding clinical management and advancing the understanding of collagen IV-related kidney diseases. Moreover, this study emphasizes the need for further research to elucidate the intricate interplay between genetic variants and histological and clinical phenotypes, thereby paving the way for personalized therapeutic approaches in collagen IV-associated nephropathies.
Keywords: Alport syndrome; COL4A3; COL4A5; Familial IgAN.
© 2025. The Author(s) under exclusive licence to Italian Society of Nephrology.
Conflict of interest statement
Declarations. Conflict of interest: The work presented in this paper has not been published previously. The authors have nothing to declare. Ethical approval: According to the Italian law, given the descriptive and non-interventional nature of the study, formal approval by the ethics committee was not requested. Human and animal rights: The present study complies with the guideline for human studies. This study does not contain any studies with animals. Informed consent: All patients gave written informed consent with permission to use their data pseudonymized for research purposed.
Similar articles
-
Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome.Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35419377 Free PMC article.
-
Digenic Alport Syndrome.Clin J Am Soc Nephrol. 2022 Nov;17(11):1697-1706. doi: 10.2215/CJN.03120322. Epub 2022 Jun 8. Clin J Am Soc Nephrol. 2022. PMID: 35675912 Free PMC article. Review.
-
Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.J Am Soc Nephrol. 2023 Jan 1;34(1):132-144. doi: 10.1681/ASN.2021111447. Epub 2022 Oct 5. J Am Soc Nephrol. 2023. PMID: 36130833 Free PMC article.
-
Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.Nephron. 2019;141(3):213-218. doi: 10.1159/000495764. Epub 2019 Jan 18. Nephron. 2019. PMID: 30661074
-
Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.Am J Kidney Dis. 2021 Dec;78(6):857-864. doi: 10.1053/j.ajkd.2021.04.017. Epub 2021 Jul 8. Am J Kidney Dis. 2021. PMID: 34245817 Review.
References
-
- Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F et al (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol 14(10):2603–2610 - DOI - PubMed
LinkOut - more resources
Full Text Sources